NCT05259657
- Conditions
- Behavior, Cancer Survivors, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Jewish General Hospital Montreal, Quebec, Canada
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,107 public trials
2,039 recruiting studies
Lymphoproliferative Disorders trial results
Completed
Peripheral Airway Biopsy in Sarcoidosis
NCT05759221
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
- Locations
-
- Fondazione Policlinico Univeristario A. Gemelli IRCCS Roma, Italy
Completed
Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)
NCT04554485
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University Hospital Brno, Internal hematology and oncology clinic Brno, Czechia
- University Hospital Hradec Kralove,The 4th Department of Internal Medicine - Hematology Hradec Králové, Czechia
- University Hospital Olomouc, Hematooncology Clinic Olomouc, Czechia
- University Hospital Ostrava, Hematooncology Clinic Ostrava, Czechia
NCT02341014
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering Westchester Harrison, New York, United States
NCT03310619
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Local Institution - 011 Duarte, California, United States
- Local Institution - 022 Atlanta, Georgia, United States
- Local Institution - 014 Chicago, Illinois, United States
- Local Institution - 012 Boston, Massachusetts, United States
NCT03959241
- Conditions
- Acute Leukemia, Anemia, Anemia, Refractory, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope National Medical Center Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- Stanford Hospital and Clinics Stanford, California, United States
Completed
NPO Before Sedation
NCT05810532
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Kangbuk Samsung Hospital Seoul, South Korea
Completed
A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma
NCT03722147
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beiing, China
NCT05306587
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
Completed
Bone Healing During Ninlaro Exposure
NCT04028115
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark